Subscribe To
Glaxosmithkline beats expectations boosted by covid-19 treatment. the stock is up.
The British drugmaker's antibody treatment for Covid-19 generated sales of £1.3 billion during the qua...
April 27, 2022, 4:55 am
Ambrx biopharma's arx788 selected for phase 2 adaptive breast cancer trial
Quantum Leap Healthcare Collaborative and Ambrx Biopharma Inc (NYSE: AMAM) have announced the selection of Ambrx's antibody-drug conjugate (ADC) A...
April 26, 2022, 11:54 am
Astrazeneca says tremelimumab accepted for us priority review for imfinzi combo for liver cancer treatment
AstraZeneca PLC (LSE:AZN) said its Biologics License Application (BLA) for tremelimumab, an anti-CTLA4 antibody, has been accepted for Priority Revie...
April 25, 2022, 2:39 am
Regeneron (regn) regen-cov bla review extended by 3 months
Regeneron (REGN) biologics license application for antibody cocktail REGEN-COV (casirivimab and imdevim...
April 18, 2022, 1:32 pm
Revive therapeutics touts publication of positive research data with bucillamine in coronavirus
Revive Therapeutics Ltd (CSE:RVV, OTCQB:RVVTF) announced the publication of a scientific article evaluating the impact of medication, including Bucill...
April 18, 2022, 11:44 am
Actinium (atnm) up on commercialization deal with immedica
Actinium (ATNM) out-licenses exclusive rights to Iomab-B, an antibody radiation conjugate for facilitat...
April 13, 2022, 6:04 pm
Cytodyn touts publication of paper on suppression of human and simian immunodeficiency virus replication with leronlimab
CytoDyn Inc, a late-stage biotechnology company developing its flagship drug leronlimab for multiple indications, has revealed the publication of a p...
April 12, 2022, 11:24 am
antibody treatments for covd-19 face challenges in the u.s.
With the emergence of the highly transmissible Omicron variant, the authorized antibody treatments of c...
April 8, 2022, 10:32 am
Twist bioscience inks antibody discovery pact with medisix therapeutics
Twist Bioscience Corporation (NASDAQ: TWST) and MediSix Therapeutics have collaborated to discover novel antibodies against five undisclosed targe...
April 7, 2022, 12:14 pm
Astrazeneca has cracked a whole new cancer treatment market, but how much is worth?
Research on AstraZeneca PLC (LSE:AZN) by JP Morgan underlined the scale of the opportunity on offer for the micro-cap life sciences companies developi...
April 7, 2022, 8:38 am
Zai lab to present new oncology research at 2022 aacr annual meeting
- First preview of preclinical data for ZL-1218, an anti-CCR8 antibody, in an oral presentation...
April 6, 2022, 8:01 am
Coronvirus tally: fda pulls glaxo covid treatment ahead of panel meeting on next steps for 2022
GlaxoSmithKline's GSK, +1.87% IV drug for COVID-19 should no longer be used because it is likely ineffective against the omicron subvariant that now a...
April 6, 2022, 6:28 am
Why adagio therapeutics stock is soaring today
Adagio Therapeutics Inc (NASDAQ: ADGI) is trading higher Wednesday after the company announced its investigational drug adintrevimab (ADG20) was the...
March 30, 2022, 10:23 am
Vir's stock is up 12% after news it will join the s&p smallcap 600
Shares of Vir Biotechnology Inc. VIR, +15.99% were up 12.8% in premarket trading on Wednesday, the day after it was announced that the stock will join...
March 30, 2022, 9:31 am
Astrazeneca (azn) gets eu nod for covid-19 antibody cocktail
The European Commission approves AstraZeneca's (AZN) Evusheld for the pre-exposure prophylaxis of COVID-19 infection in a broad patient population....
March 28, 2022, 1:33 pm
Fda says current dose of gsk-vir's covid-19 therapy unlikely to work against omicron subvariant
The FDA said that the currently authorized 500mg dose of GlaxoSmithKline Plc (NYSE: GSK) and Vir Biotechnology Inc's (NASDAQ: VIR) COVID-19 ...
March 28, 2022, 10:47 am
Astrazeneca's covid drug bags eu approval
AstraZeneca PLC (LSE:AZN) has received EU marketing authorisation for its Evusheld antibody combination...
March 28, 2022, 5:13 am
Why is biondvax (bvxv) stock up today?
BVXV stock is climbing today on news that BiondVax has struck a deal to pursue a range of antibody trea...
March 24, 2022, 1:15 pm
Here's why biondvax pharmaceuticals shares are rising
Biondvax Pharmaceuticals Ltd - ADR (NASDAQ: BVXV) shares are trading higher by 32.1% at $1.81 after the company announced it signed a definitive coll...
March 24, 2022, 12:03 pm
Soligenix's covid-19 vaccine candidate as booster neutralizes delta, omicron variants
Soligenix Inc (NASDAQ: SNGX) announced the results of a booster vaccination study using CiVax (heat-stable COVID-19 subunit vaccine program) in non...
March 17, 2022, 9:44 am